Close
Close
Treatment Database
T-cell depleted stem cell enriched cellular product from peripheal b lood stem cells
Trade Name not avaiable
Orphan Indication Chronic granulomatous disease
USA Market Approval
USA Designation Date 01-11-2001
Sponsor Nexell Therapeutics Inc.
9 Parker
Irvine, California, 92618
More about Chronic granulomatous disease
Free Newsletter
Related Videos
by Harish Ravi
2,569 views
by Xuan Shao
4,191 views